Enhabit, Inc. (NYSE:EHAB) Short Interest Update

Enhabit, Inc. (NYSE:EHAB) was the target of a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 1,220,000 shares, a decrease of 5.4% from the December 15th total of 1,290,000 shares. Based on an average trading volume of 375,300 shares, the days-to-cover ratio is presently 3.3 days. Approximately 2.8% of the shares of the stock are sold short.

Insiders Place Their Bets

In other news, Director Stuart M. Mcguigan acquired 15,000 shares of the business’s stock in a transaction dated Tuesday, December 10th. The stock was purchased at an average cost of $8.81 per share, for a total transaction of $132,150.00. Following the acquisition, the director now owns 46,810 shares of the company’s stock, valued at $412,396.10. This trade represents a 47.15 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jeffrey Bolton acquired 4,000 shares of the business’s stock in a transaction dated Thursday, December 12th. The stock was purchased at an average price of $8.69 per share, with a total value of $34,760.00. Following the completion of the acquisition, the director now directly owns 98,144 shares in the company, valued at approximately $852,871.36. This represents a 4.25 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 1.90% of the company’s stock.

Institutional Investors Weigh In On Enhabit

A number of large investors have recently made changes to their positions in EHAB. FMR LLC lifted its stake in shares of Enhabit by 138.4% in the 3rd quarter. FMR LLC now owns 3,388 shares of the company’s stock valued at $27,000 after purchasing an additional 1,967 shares during the period. Quarry LP lifted its stake in shares of Enhabit by 242.2% in the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock valued at $33,000 after purchasing an additional 2,621 shares during the period. Gladius Capital Management LP lifted its stake in shares of Enhabit by 78.2% in the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock valued at $49,000 after purchasing an additional 2,747 shares during the period. Stoneridge Investment Partners LLC purchased a new position in shares of Enhabit in the 3rd quarter valued at approximately $81,000. Finally, Canada Pension Plan Investment Board purchased a new position in shares of Enhabit in the 2nd quarter valued at approximately $93,000.

Enhabit Price Performance

EHAB opened at $7.99 on Friday. The stock’s 50 day simple moving average is $7.83 and its 200 day simple moving average is $8.11. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. Enhabit has a 1 year low of $6.85 and a 1 year high of $11.74. The firm has a market cap of $401.52 million, a price-to-earnings ratio of -3.44 and a beta of 1.82.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The business had revenue of $253.60 million during the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same quarter in the prior year, the business posted $0.03 earnings per share. As a group, analysts predict that Enhabit will post 0.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Leerink Partners reiterated a “market perform” rating and issued a $8.00 price objective (down from $8.50) on shares of Enhabit in a report on Tuesday, November 19th. Jefferies Financial Group upgraded Enhabit from a “hold” rating to a “buy” rating and increased their target price for the company from $8.25 to $9.50 in a report on Monday, December 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $8.75.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.